COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

IP International Journal of Medical Paediatrics and Oncology

Conjugated Fraction in Neonatal Hyperbilirubinemia- Factors Associated and Influence on Outcome?

Full Text PDF

Author Details: Ngangbam Sonamani, Ghanshyam Das, Waseem Iqbal, Shobha B, Sunil Bhat

Volume : 2

Issue : 1

Online ISSN : 2581-4702

Print ISSN : 2581-4699

Article First Page : 1

Article End Page : 6


Objective: To evaluate the factors associated with conjugated hyperbilirubinemia and its contribution to outcome and prognosis of neonates with jaundice.
Design: A prospective and observational study.
Setting: Kamla Raja Hospital, G. R. Medical College, Gwalior (M.P.) for a period of 1 year.
Participants: Consecutive term and late preterm LBW neonates reporting with hyperbilirubinemia to the center were recruited in the study.
Method: Relevant history, clinical findings and appropriate laboratory investigations of the eligible cohort were obtained and the cohort was followed-up till discharge or final outcome to assess the risk, the time to and the rate of mortality(n=126).
Results:  The median values of total, conjugated and unconjugated bilirubin in the cohort were 18.6 (IQR 7.2), 2.8 (IQR 2.1) and 15.3 (IQR 6.425) mg/dl respectively. These values were used to dichotomize the variables into high and low. A strong association was observed between perinatal hypoxic ischemia and conjugated hyperbilirubinemia (p=0.026, χ2=4.214, κ=0.144, odds ratio=3.886). Conjugated hyperbilirubinemia was found to be strongly associated with sepsis indicating the probable role of sepsis in conjugated hyperbilirubinemia (p<0.001, κ=0.313). Unconjugated hyperbilirubinemia contributed more in terms of number of patients (54.77% vs 45.23%), while maximum proportion of death occurred in neonates with conjugated hyperbilirubinemia (71.42% vs 28.58%). The z values for conjugated bilirubin were significantly higher in those neonates who died when compared to those who survived (p=0.0005), while the z values for unconjugated bilirubin were similar in neonates who died and who survived (Mann Whitney box plots). Further, comparison of ROC curves (AUC 0.824 vs 0.526; SE 0.0688 vs 0.104; p=0.0437) indicated a superior prognostic value of conjugated fraction in predicting death.
Conclusion: The study showed that conjugated bilirubin is a dependable clinical parameter for prognostication of neonates with hyperbilirubinemia. Conjugated bilirubin measurement may be put to greater use in our population where factors associated with conjugated hyperbilirubinemia as sepsis and perinatal hypoxia are quite prevalent.

Key words:
Conjugated bilirubin, Hyperbilirubinemia, Neonatal Jaundice

Doi No:-10.18231